Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection

Keyphrases

• Glioblastoma 100%
• Nanomedicine 100%
• Surgical Resection 100%
• Resection Cavity 100%
• Local Chemotherapy 100%
• Tumor 33%
• Standard of Care 33%
• Tumor Recurrence 33%
• Blood-brain Barrier 33%
• Cytotoxicity 33%
• Gemcitabine 33%
• Mouse Brain 33%
• Orthotopic Xenograft Model 33%
• Intratumoral Administration 33%
• Local Delivery 33%
• U251 33%
• Temozolomide 33%
• Tumor Resection 33%
• Oral Chemotherapy 33%
• Chemoradiation 33%
• Patient Death 33%
• LacZ 33%
• Mouse Survival 33%
• Post-resection 33%
• Promising Strategies 33%
• U87MG 33%
• Lipid Nanocapsules 33%
• Glioblastoma Therapy 33%
• Local Concentration 33%
• Glioblastoma Resection 33%
• Internalization Mechanism 33%
• Well Tolerated 33%
• Radiotherapy Chemotherapy 33%
• Glioblastoma Cell Line 33%

Neuroscience

• Chemotherapy 100%
• Cell Line 50%
• Blood Brain Barrier 50%
• Cytotoxicity 50%
• Internalization 50%
• Gemcitabine 50%
• Temozolomide 50%
• Radiation Therapy 50%
• Lipid 50%
• Mouse Brain 50%